| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |